NEXGEL, Inc. (NXGL) - Full Takeover Company Value

Official company branding of NEXGEL Inc (NXGL)

The current market quotes for NEXGEL, Inc. (NXGL) visualized below rely on profit protection via radiation cross-linking patents and FDA certifications, with an Enterprise Value of 19.35. The business is based on the creation of innovative hydrogels, integrating its patches into the product lines of global brands. Additionally, NEXGEL, Inc. (NXGL) capitalizes on physician trust by producing smart patches for transdermal drug delivery and cooling.

NXGL (NEXGEL, Inc) Total Company Value history from 11/23/2025 to 10/28/2026

NXGL (NEXGEL, Inc.): analytical breakdowns and indicator data

- price and consensus price forecast:
Share Price NEXGEL Inc.|NXGL - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization NEXGEL|NXGL - Total Company Value
- book capitalization data:
Net Assets per Single Share NEXGEL|NXGL - Company Book Value|Market Cap to Net Assets Ratio nexgel.com|NXGL - Company Total Assets
- debt and liquidity data:
Debt to Capital NEXGEL, Inc.|NXGL - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio nexgel.com|NXGL - Company Aggregate Debts|Debts to Net Assets NEXGEL|NXGL - Company Long-Term Debts|Company Current Liabilities NEXGEL
General company analysis:NXGL (NEXGEL Inc.)
Original product of NEXGEL Inc.

NEXGEL, Inc. (NXGL) diversification across the medical and cosmetics segments determines the fundamental value of its business. This total buyout price for the company on GURU.Markets aggregates market capitalization and debt, excluding available cash. Such a calculation reflects the actual costs of acquiring all assets. This indicator's trend allows speculative noise to be filtered out from true growth. High values increase the risk of a correction should market expectations shift.

Competitor analysis for NEXGEL, Inc.

Business Value Intuitive Surgical, Inc. ISRG|Enterprise Value DHR|BDX: Full Takeover Company Value|STERIS plc (STE) - Total Company Value|WST (westpharma.com) - Total Company Value|Total Company Value BAX|Real Price to Acquire Entire Company Masimo Corp|Stevanato - Enterprise Value|Total Enterprise Value Teleflex Corp (TFX)|MMSI - Enterprise Value|Business Value envistaco.com NVST|Enterprise Value ICUI (ICU Medical)|XRAY - Company Buyout Price|LMAT (LeMaitre) - Enterprise Value|AtriCure Medical (ATRC) - Real Price to Acquire Entire Company|STAA (STAAR Surgical Company) - Enterprise Value|Enterprise Value NAGE|Total Company Value ZimVie (ZIMV)|Total Company Value AngioDynamics Inc ANGO|Real Price to Acquire Entire Company Cerus Corp|Value Adjusted for Debt and Cash Teknova Inc TKNO|Enterprise Value MGRM (Monogram Technologies)|STSS: Company Buyout Price|Total Company Value infusystem.com|UTMD (Utah Medical Products Inc.) - Business Value|KRMD: Total Company Value|Company Buyout Price Nyxoah S.A (NYXH)|Real Price to Acquire Entire Company Microbot Medical Inc.|Aggregate Business Value PDEX (pro-dex.com)|Total Company Value Zentek|ELUT - Value Adjusted for Debt and Cash|Milestone Scientific Corp - Real Price to Acquire Entire Company|RVP: Enterprise Value|HBIO (Harvard Bioscience) - Total Company Value|femasys.com (FEMY) - Real Price to Acquire Entire Company|Enterprise Value MHUA (Meihua Medical Technologies)|Total Enterprise Value POAI|Total Company Value Callan JMB Inc CJMB|Business Value Atrion Corporation Inc. ATRI|Real Price to Acquire Entire Company NeuroMetrix, Inc. (NURO)